This cohort study evaluated the comorbidity burden and long-term outcomes — including overall, waiting-list, and post–liver transplant mortality — in patients with metabolic dysfunction–associated steatohepatitis (MASH) on the liver transplant waiting list.
Only the abstract was available; full-text data including sample size, specific outcomes, and statistical results could not be extracted.
Explore related topics
